Status:

COMPLETED

Ring-type Pulse Oximeter for Evaluation for Sleep Assessment Study

Lead Sponsor:

Belun Technology Company Limited

Collaborating Sponsors:

Stanford University

Conditions:

Sleep-Disordered Breathing

Sleep Architecture

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

Recently, various electronic lifestyle activity monitoring devices (ELAM) are increasingly commercially available. However, the quality and reliability of the data from ELAM are unclear, compared with...

Eligibility Criteria

Inclusion

  • Age between 18 to 80 years old. Ideally balanced for sex and age (18 to 80 years old)
  • no more than 75% of subjects in one bin of: (male, female)
  • no more than 50% of subjects in one age-group (18-29, 30-39, 40-49, 50-59, 60-80)
  • Patients with OSA symptoms (snoring, excessive daytime sleepiness or witnessed apnea, etc.)
  • Without any unstable medical or psychiatric co-morbidities that would be expected to interfere with the study.
  • If taking any medication, must be on a stable dose of medication for a month
  • Able to read and understand English

Exclusion

  • Presence of any significant systemic or unstable medical condition which could lead to difficulty complying with the protocol, suicidality, current regular use of psychiatric medications, opiates, or thyroid medications, dementia, current substance abuse, post-traumatic or psychotic disorders, bipolar disorder; any significant neurologic disease, including possible and probable dementia, Parkinson's or Huntington's disease, brain tumor, progressive supranuclear palsy, seizure disorder, subdural hematoma, multiple sclerosis, history of significant head trauma, history of alcohol or substance use disorder within the past 2 years (DSM V criteria);
  • If positive airway pressure (PAP) titration study or split night study (diagnostic and PAP titration study combined)

Key Trial Info

Start Date :

July 15 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 12 2023

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT06221124

Start Date

July 15 2020

End Date

June 12 2023

Last Update

January 24 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Stanford Sleep Medecine Center

Redwood City, California, United States, 94063